Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundupByBruce GilPublishedMarch 7, 2025
Big Pharma wants to bring back a tax break that could save it $15 billionByBruce GilPublishedMarch 6, 2025
The price to listen to Alex Cooper and Howard Stern on SiriusXM might change — thanks to tariffsByBruce GilPublishedMarch 6, 2025
Now playing Ozempic competitor in the works at Amgen reaches late-stage clinical trialsPublishedMarch 5, 2025
Now playing Amgen just got one step closer to bringing its Ozempic competitor to marketByBruce GilUpdatedMarch 5, 2025
A 'Divergent' producer wants to use AI to make 30 new projects in the next 4 yearsByBruce GilUpdatedMarch 4, 2025
Over half of adults could be overweight by 2050. Why weight loss drugs aren't a cureByBruce GilUpdatedMarch 4, 2025
This company edited mice genes to make them more like woolly mammothsByBruce GilPublishedMarch 4, 2025
Pfizer CEO says he's prepared to shift manufacturing to the U.S. amid tariff threatsByBruce GilUpdatedMarch 3, 2025
